{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:46:21Z","timestamp":1788684381356,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Directorate of Higher Education"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jcv.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:24:37Z","timestamp":1560165877000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Characterization of antibody response in patients with acute and chronic chikungunya virus disease"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-0635","authenticated-orcid":false,"given":"Fatih","family":"Anfasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fekken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron E.E.","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2019.06.001_bib0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/590003","article-title":"Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island","volume":"47","author":"Borgherini","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0010","doi-asserted-by":"crossref","first-page":"e2137","DOI":"10.1371\/journal.pntd.0002137","article-title":"Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study","volume":"7","author":"Schilte","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-virology-101416-041808","article-title":"Immunopathology of Chikungunya virus infection: lessons learned from patients and animal models","volume":"4","author":"Ng","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41426-017-0010-0","article-title":"Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community","volume":"7","author":"Auerswald","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jcv.2019.06.001_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-11-183","article-title":"Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand","volume":"11","author":"Nitatpattana","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.jcv.2019.06.001_bib0030","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/jmv.22134","article-title":"Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children","volume":"83","author":"Freitas","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0035","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0040","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1073\/pnas.96.22.12708","article-title":"Humoral response to herpes simplex virus is complement-dependent","volume":"96","author":"Da Costa","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2019.06.001_bib0045","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1128\/JVI.79.12.7466-7477.2005","article-title":"Complement activation is required for induction of a protective antibody response against West Nile virus infection","volume":"79","author":"Mehlhop","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/infdis\/141.2.212","article-title":"The role of complement in viral infections. II. the clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement","volume":"141","author":"Hirsch","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0055","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.124.5.2507","article-title":"The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus","volume":"124","author":"Hirsch","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/iai.30.3.899-901.1980","article-title":"Role of complement in viral infections: participation of terminal complement components (C5 to C9) in recovery of mice from Sindbis virus infection","volume":"30","author":"Hirsch","year":"1980","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jcv.2019.06.001_bib0065","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1128\/JVI.02799-06","article-title":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease","volume":"81","author":"Morrison","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2016.11.003","article-title":"Hyperferritinemia is a potential marker of chronic chikungunya: a retrospective study on the Island of Curacao during the 2014-2015 outbreak","volume":"86","author":"Anfasa","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0075","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1373\/clinchem.2007.086595","article-title":"Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus","volume":"53","author":"Laurent","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jcv.2019.06.001_bib0080","doi-asserted-by":"crossref","first-page":"e3101","DOI":"10.1371\/journal.pntd.0003101","article-title":"Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge","volume":"8","author":"van den Doel","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0085","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven behandlung pharmakologischer reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch. Exp. Pathol. Pharmakol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.125.3248.600","article-title":"Dissociation of human serum macroglobulins","volume":"125","author":"Deutsch","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.jcv.2019.06.001_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcv.2019.06.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171989","article-title":"The neutralizing role of IgM during early Chikungunya virus infection","volume":"12","author":"Chua","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2019.06.001_bib0105","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","article-title":"An essential role of antibodies in the control of Chikungunya virus infection","volume":"190","author":"Lum","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2019.06.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02449-17","article-title":"Chikungunya virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models","volume":"9","author":"Langsjoen","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.jcv.2019.06.001_bib0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1099\/0022-1317-81-2-471","article-title":"Re-emergence of Chikungunya and O\u2019nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships","volume":"81","author":"Powers","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0125","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection","volume":"205","author":"Kam","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","article-title":"Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus","volume":"6","author":"Mehlhop","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcv.2019.06.001_bib0140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1126\/science.276.5321.2024","article-title":"The role of antibody concentration and avidity in antiviral protection","volume":"276","author":"Bachmann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jcv.2019.06.001_bib0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/513996","article-title":"Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women","volume":"175","author":"Grangeot-Keros","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0150","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/cid\/cit059","article-title":"Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort","volume":"56","author":"Leruez-Ville","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.06.001_bib0155","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/CVI.00032-07","article-title":"Humoral immune response after primary rubella virus infection and after vaccination","volume":"14","author":"Vauloup-Fellous","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/9473","article-title":"Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody","volume":"5","author":"Polack","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2019.06.001_bib0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm918","article-title":"A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles","volume":"9","author":"Polack","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2019.06.001_bib0170","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jcv.2019.06.001_bib0175","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1128\/JCM.13.5.888-890.1981","article-title":"Choice and specificity of complement in complement fixation assay","volume":"13","author":"Sethi","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.06.001_bib0180","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s12275-017-7478-0","article-title":"Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines","volume":"55","author":"Kim","year":"2017","journal-title":"J. Microbiol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:56:55Z","timestamp":1694930215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219301398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S1386653219301398"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.06.001","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of antibody response in patients with acute and chronic chikungunya virus disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}